GOCO
GOCO
GoHealth, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $34.19M ▼ | $302.01M ▲ | $-165.85M ▼ | -485.13% ▼ | $-13.52 ▼ | $-262.62M ▼ |
| Q2-2025 | $94.05M ▼ | $161.02M ▼ | $-54.28M ▼ | -57.71% ▼ | $-5.1 ▼ | $-73.2M ▼ |
| Q1-2025 | $220.97M ▼ | $190.79M ▼ | $-4.41M ▼ | -1.99% ▼ | $-0.52 ▼ | $33.75M ▼ |
| Q4-2024 | $389.13M ▲ | $256.63M ▲ | $25.51M ▲ | 6.56% ▲ | $2.42 ▲ | $105.03M ▲ |
| Q3-2024 | $118.29M | $137.45M | $6.78M | 5.73% | $0.58 | $60.86M |
What's going well?
There are very few positives this quarter. The company managed to cut sales and marketing expenses, and a higher share count may have brought in some cash.
What's concerning?
Revenue plunged 64%, gross profit collapsed, and losses tripled. Expenses are out of control, and the company is burning cash fast. Shareholder dilution is also a concern.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $32.08M ▼ | $1.03B ▼ | $1.04B ▲ | $68.17M ▼ |
| Q2-2025 | $35.59M ▲ | $1.31B ▼ | $977.08M ▲ | $246.66M ▼ |
| Q1-2025 | $22.15M ▼ | $1.38B ▼ | $931.06M ▼ | $295.55M ▲ |
| Q4-2024 | $40.92M ▲ | $1.49B ▲ | $1.03B ▲ | $294.8M ▲ |
| Q3-2024 | $35.53M | $1.34B | $943.87M | $264.06M |
What's financially strong about this company?
There is no goodwill or intangible asset risk, and most assets are in cash or receivables, which are easier to turn into cash if collected.
What are the financial risks or weaknesses?
The company has negative equity, very little cash, and a huge jump in receivables, suggesting customers may not be paying. Debt is high and rising, and liquidity has collapsed.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-165.85M ▼ | $-32.22M ▲ | $-2.37M ▲ | $30.99M ▼ | $-3.51M ▼ | $-34.59M ▲ |
| Q2-2025 | $-115.99M ▼ | $-37.82M ▼ | $-2.83M ▲ | $53.86M ▲ | $13.44M ▲ | $-40.65M ▼ |
| Q1-2025 | $-9.79M ▼ | $-12.4M ▼ | $-3.05M ▼ | $-3.2M ▲ | $-18.77M ▼ | $-15.45M ▼ |
| Q4-2024 | $57.98M ▲ | $14.6M ▲ | $-2.22M ▼ | $-6.97M ▼ | $5.39M ▼ | $12.39M ▲ |
| Q3-2024 | $-30.08M | $-12.23M | $13.28M | $20.33M | $21.4M | $-16.48M |
What's strong about this company's cash flow?
Cash burn is shrinking, and the company was able to collect a large amount of receivables, which temporarily improved cash flow. Capital spending is low, so less cash is needed for maintenance.
What are the cash flow concerns?
GOCO is still losing money and burning cash from operations, with no sign of self-sufficiency. The company depends on borrowing to survive, and the recent cash boost is likely a one-time event.
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Agency Revenue | $0 ▲ | $0 ▲ | $80.00M ▲ | $30.00M ▼ |
Commission | $200.00M ▲ | $170.00M ▼ | $0 ▼ | $0 ▲ |
Medicare Revenue | $0 ▲ | $0 ▲ | $90.00M ▲ | $30.00M ▼ |
Product and Service Other | $0 ▲ | $0 ▲ | $10.00M ▲ | $10.00M ▲ |
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at GoHealth, Inc.'s financial evolution and strategic trajectory over the past five years.
GoHealth’s key strengths are its improving income statement, strong gross economics, and sophisticated technology platform tailored to a complex and growing Medicare market. The company has demonstrated that it can grow revenue again after a setback, materially improve margins, and leverage data and AI to enhance both agent productivity and consumer experience. It also maintains meaningful carrier relationships and a recognizable brand in its niche.
The main risks center on financial fragility and competitive intensity. The balance sheet shows rising leverage and thinning liquidity, while cash flow has swung back to significant outflows despite better reported margins. Accumulated losses and declining retained earnings signal that past difficulties still weigh on the capital structure. At the same time, GoHealth faces aggressive competition, regulatory uncertainty, and execution risk as it expands into value-based care and new product areas.
The overall trajectory looks cautiously constructive but not yet secure. Operational metrics and profitability trends point to a real turnaround, and the strategic shift toward a more integrated, data-driven health platform offers meaningful long-term opportunity. However, the company still needs to prove it can convert this improving profile into durable free cash flow, reduced leverage, and a stronger balance sheet. Future performance will depend heavily on disciplined execution, stable regulatory conditions, and the company’s ability to defend and deepen its competitive advantages.
About GoHealth, Inc.
https://www.gohealth.comGoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: Medicare—Internal; Medicare—External; Individual and Family Plans (IFP) and Other—Internal; and IFP and Other—External.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $34.19M ▼ | $302.01M ▲ | $-165.85M ▼ | -485.13% ▼ | $-13.52 ▼ | $-262.62M ▼ |
| Q2-2025 | $94.05M ▼ | $161.02M ▼ | $-54.28M ▼ | -57.71% ▼ | $-5.1 ▼ | $-73.2M ▼ |
| Q1-2025 | $220.97M ▼ | $190.79M ▼ | $-4.41M ▼ | -1.99% ▼ | $-0.52 ▼ | $33.75M ▼ |
| Q4-2024 | $389.13M ▲ | $256.63M ▲ | $25.51M ▲ | 6.56% ▲ | $2.42 ▲ | $105.03M ▲ |
| Q3-2024 | $118.29M | $137.45M | $6.78M | 5.73% | $0.58 | $60.86M |
What's going well?
There are very few positives this quarter. The company managed to cut sales and marketing expenses, and a higher share count may have brought in some cash.
What's concerning?
Revenue plunged 64%, gross profit collapsed, and losses tripled. Expenses are out of control, and the company is burning cash fast. Shareholder dilution is also a concern.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $32.08M ▼ | $1.03B ▼ | $1.04B ▲ | $68.17M ▼ |
| Q2-2025 | $35.59M ▲ | $1.31B ▼ | $977.08M ▲ | $246.66M ▼ |
| Q1-2025 | $22.15M ▼ | $1.38B ▼ | $931.06M ▼ | $295.55M ▲ |
| Q4-2024 | $40.92M ▲ | $1.49B ▲ | $1.03B ▲ | $294.8M ▲ |
| Q3-2024 | $35.53M | $1.34B | $943.87M | $264.06M |
What's financially strong about this company?
There is no goodwill or intangible asset risk, and most assets are in cash or receivables, which are easier to turn into cash if collected.
What are the financial risks or weaknesses?
The company has negative equity, very little cash, and a huge jump in receivables, suggesting customers may not be paying. Debt is high and rising, and liquidity has collapsed.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-165.85M ▼ | $-32.22M ▲ | $-2.37M ▲ | $30.99M ▼ | $-3.51M ▼ | $-34.59M ▲ |
| Q2-2025 | $-115.99M ▼ | $-37.82M ▼ | $-2.83M ▲ | $53.86M ▲ | $13.44M ▲ | $-40.65M ▼ |
| Q1-2025 | $-9.79M ▼ | $-12.4M ▼ | $-3.05M ▼ | $-3.2M ▲ | $-18.77M ▼ | $-15.45M ▼ |
| Q4-2024 | $57.98M ▲ | $14.6M ▲ | $-2.22M ▼ | $-6.97M ▼ | $5.39M ▼ | $12.39M ▲ |
| Q3-2024 | $-30.08M | $-12.23M | $13.28M | $20.33M | $21.4M | $-16.48M |
What's strong about this company's cash flow?
Cash burn is shrinking, and the company was able to collect a large amount of receivables, which temporarily improved cash flow. Capital spending is low, so less cash is needed for maintenance.
What are the cash flow concerns?
GOCO is still losing money and burning cash from operations, with no sign of self-sufficiency. The company depends on borrowing to survive, and the recent cash boost is likely a one-time event.
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Agency Revenue | $0 ▲ | $0 ▲ | $80.00M ▲ | $30.00M ▼ |
Commission | $200.00M ▲ | $170.00M ▼ | $0 ▼ | $0 ▲ |
Medicare Revenue | $0 ▲ | $0 ▲ | $90.00M ▲ | $30.00M ▼ |
Product and Service Other | $0 ▲ | $0 ▲ | $10.00M ▲ | $10.00M ▲ |
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at GoHealth, Inc.'s financial evolution and strategic trajectory over the past five years.
GoHealth’s key strengths are its improving income statement, strong gross economics, and sophisticated technology platform tailored to a complex and growing Medicare market. The company has demonstrated that it can grow revenue again after a setback, materially improve margins, and leverage data and AI to enhance both agent productivity and consumer experience. It also maintains meaningful carrier relationships and a recognizable brand in its niche.
The main risks center on financial fragility and competitive intensity. The balance sheet shows rising leverage and thinning liquidity, while cash flow has swung back to significant outflows despite better reported margins. Accumulated losses and declining retained earnings signal that past difficulties still weigh on the capital structure. At the same time, GoHealth faces aggressive competition, regulatory uncertainty, and execution risk as it expands into value-based care and new product areas.
The overall trajectory looks cautiously constructive but not yet secure. Operational metrics and profitability trends point to a real turnaround, and the strategic shift toward a more integrated, data-driven health platform offers meaningful long-term opportunity. However, the company still needs to prove it can convert this improving profile into durable free cash flow, reduced leverage, and a stronger balance sheet. Future performance will depend heavily on disciplined execution, stable regulatory conditions, and the company’s ability to defend and deepen its competitive advantages.

CEO
Vijay Kumar Kotte
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2022-11-18 | Reverse | 1:15 |
ETFs Holding This Stock
Summary
Showing Top 3 of 46
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
CENTERBRIDGE PARTNERS, L.P.
Shares:4.18M
Value:$5.73M
PUBLIC SECTOR PENSION INVESTMENT BOARD
Shares:1.68M
Value:$2.3M
REDWOOD CAPITAL MANAGEMENT, LLC
Shares:924.24K
Value:$1.27M
Summary
Showing Top 3 of 74

